BGM
BGM Group Ltd.
Price Chart
Latest Quote
$0.39
-0.06 (-12.59%)
Current Price
| Previous Close | $0.44 |
| Open | $0.43 |
| Day High | $0.43 |
| Day Low | $0.38 |
| Volume | 82,803 |
Stock Information
| Shares Outstanding | 180.62M |
| Total Debt | $1.78M |
| Cash Equivalents | $14.54M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $77.88M |
| EPS (TTM) | $-0.29 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $32.26M |
| Book/sh | $1.85 |
| Cash/sh | $0.08 |
Financial Ratios
| Debt/Eq | 0.97 |
Returns & Margins
| Operating Margin | -15.64% |
Ownership
| Insider Ownership | 23.83% |
| Institutional Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 0.21 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.34 |
| SMA50 | $0.32 |
| SMA200 | $4.14 |
| RSI | 56.43 |
| ATR | 0.0666 |
| Short Float | 0.24% |
| Short Ratio | 0.78 |
| Rel Volume | 0.16 |
Performance History
| Week | -8.71% |
| Month | +41.09% |
| Quarter | -55.25% |
| 6 Months | -92.50% |
| YTD | -89.16% |
| Year | -97.25% |
| 3 Years | -91.13% |
| 5 Years | -98.27% |
| 10 Years | -99.20% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.39 | 98,600 |
| 2026-06-16 | $0.44 | 243,100 |
| 2026-06-15 | $0.46 | 1,476,600 |
| 2026-06-12 | $0.38 | 418,100 |
| 2026-06-11 | $0.34 | 841,600 |
| 2026-06-10 | $0.43 | 6,082,700 |
| 2026-06-09 | $0.34 | 299,400 |
| 2026-06-08 | $0.32 | 337,700 |
| 2026-06-05 | $0.29 | 164,300 |
| 2026-06-04 | $0.32 | 1,382,500 |
| 2026-06-03 | $0.29 | 85,400 |
| 2026-06-02 | $0.32 | 43,900 |
| 2026-06-01 | $0.32 | 80,000 |
| 2026-05-29 | $0.32 | 244,900 |
| 2026-05-28 | $0.32 | 43,700 |
| 2026-05-27 | $0.32 | 101,400 |
| 2026-05-26 | $0.31 | 115,000 |
| 2026-05-22 | $0.29 | 31,000 |
| 2026-05-21 | $0.29 | 141,300 |
| 2026-05-20 | $0.29 | 245,200 |
| 2026-05-19 | $0.28 | 268,000 |
| 2026-05-18 | $0.28 | 627,300 |
About BGM Group Ltd.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform. BGM Group Ltd. is based in Chengdu, China.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $20,983,196 | $44,719,984 | $58,627,728 | $51,461,354 |
| Cost Of Revenue | $20,983,196 | $44,719,984 | $58,627,728 | $51,461,354 |
| Total Revenue | $25,097,951 | $46,471,478 | $64,855,025 | $57,099,884 |
| Operating Revenue | $25,097,951 | $46,471,478 | $64,855,025 | $57,099,884 |
| Expenses | ||||
| Total Expenses | $25,455,307 | $48,889,202 | $62,339,305 | $54,147,741 |
| Other Income Expense | $-1,140,275 | $-5,584,370 | $-980,021 | $468,805 |
| Other Non Operating Income Expenses | $-14,841 | $-61,005 | $-167,217 | $6,791 |
| Net Non Operating Interest Income Expense | $-639,511 | $99,190 | $24,860 | $-57,671 |
| Total Other Finance Cost | $639,511 | $-99,190 | $-24,860 | $57,671 |
| Operating Expense | $4,472,111 | $4,169,218 | $3,711,577 | $2,686,387 |
| Other Operating Expenses | $-206,415 | $-192,375 | $-413,717 | $-564,098 |
| Selling And Marketing Expense | $592,839 | $961,679 | $751,428 | - |
| General And Administrative Expense | $2,724,188 | $2,831,444 | $2,149,522 | - |
| Interest Expense | - | - | - | $57,671 |
| Interest Expense Non Operating | - | - | - | $57,671 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,442,830 | $-7,780,620 | $1,076,693 | $3,152,868 |
| Net Interest Income | $-639,511 | $99,190 | $24,860 | $-57,671 |
| Normalized Income | $-789,162 | $-3,638,096 | $1,787,896 | $2,725,967 |
| Net Income From Continuing And Discontinued Operation | $-1,442,830 | $-7,780,620 | $1,076,693 | $3,152,868 |
| Total Operating Income As Reported | $-563,771 | $-2,610,099 | $2,102,003 | $2,388,045 |
| Net Income Common Stockholders | $-1,442,830 | $-7,780,620 | $1,076,693 | $3,152,868 |
| Net Income | $-1,442,830 | $-7,780,620 | $1,076,693 | $3,152,868 |
| Net Income Including Noncontrolling Interests | $-1,517,161 | $-8,122,070 | $1,366,257 | $3,108,144 |
| Net Income Continuous Operations | $-1,517,161 | $-8,122,070 | $1,366,257 | $3,108,144 |
| Pretax Income | $-2,137,142 | $-7,902,904 | $1,560,559 | $3,363,277 |
| Earnings From Equity Interest | $-204,648 | $0 | $0 | - |
| Operating Income | $-357,356 | $-2,417,724 | $2,515,720 | $2,952,143 |
| Gross Profit | $4,114,755 | $1,751,494 | $6,227,297 | $5,638,530 |
| Interest Income | - | - | $24,860 | - |
| Interest Income Non Operating | - | - | $24,860 | - |
| Per Share | ||||
| Diluted EPS | $-0.20 | $-1.08 | $0.15 | $0.45 |
| Basic EPS | $-0.20 | $-1.08 | $0.15 | $0.45 |
| Other | ||||
| Tax Effect Of Unusual Items | $-267,118 | $-1,380,841 | $-101,600 | $35,113 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,800,659 | $4,248,705 | $4,553,196 | $3,691,358 |
| Total Unusual Items | $-920,786 | $-5,523,365 | $-812,804 | $462,014 |
| Total Unusual Items Excluding Goodwill | $-920,786 | $-5,523,365 | $-812,804 | $462,014 |
| Reconciled Depreciation | $1,237,229 | $1,143,064 | $1,224,672 | $1,201,229 |
| EBITDA (Bullshit earnings) | $879,873 | $-1,274,660 | $3,740,392 | $4,153,372 |
| EBIT | $-357,356 | $-2,417,724 | $2,515,720 | $2,952,143 |
| Diluted Average Shares | $7,226,480 | $7,226,480 | $7,226,480 | $6,817,857 |
| Basic Average Shares | $7,226,480 | $7,226,480 | $7,226,480 | $6,817,857 |
| Diluted NI Availto Com Stockholders | $-1,442,830 | $-7,780,620 | $1,076,693 | $3,152,868 |
| Minority Interests | $74,331 | $341,450 | $-289,564 | $44,724 |
| Tax Provision | $-619,981 | $219,166 | $194,302 | $255,133 |
| Gain On Sale Of Security | $-920,786 | $-5,523,365 | $-812,804 | $462,014 |
| Research And Development | $1,361,499 | $568,470 | $1,224,344 | - |
| Selling General And Administration | $3,317,027 | $3,793,123 | $2,900,950 | $3,250,485 |
| Other Gand A | $2,724,188 | $2,831,444 | $2,149,522 | - |
Fetched: 2026-06-13
Balance Sheet (Annual)
| Metric | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $38,204,497 | $39,368,551 | $51,325,214 | $52,930,673 |
| Total Assets | $53,003,728 | $51,257,994 | $64,526,617 | $75,353,263 |
| Total Non Current Assets | $23,234,518 | $16,745,373 | $34,492,628 | $34,988,110 |
| Non Current Deferred Assets | $424,474 | $10,778 | $212,876 | $427,120 |
| Non Current Deferred Taxes Assets | $424,474 | $10,778 | $212,876 | $427,120 |
| Goodwill And Other Intangible Assets | $4,539,347 | $3,423,582 | $1,726,928 | $1,927,933 |
| Other Intangible Assets | $4,539,347 | $3,423,582 | $1,726,928 | $1,927,933 |
| Current Assets | $29,769,210 | $34,512,621 | $30,033,989 | $40,365,153 |
| Prepaid Assets | $803,924 | $747,331 | $1,303,832 | $1,792,457 |
| Inventory | $5,049,688 | $4,991,435 | $8,879,486 | $12,495,831 |
| Receivables | $5,774,757 | $6,354,589 | $4,871,658 | $13,469,492 |
| Other Receivables | $192,387 | $247,481 | $1,470,447 | $14,090 |
| Taxes Receivable | $702,073 | $0 | - | - |
| Notes Receivable | $3,337,137 | $4,131,392 | $2,585,886 | $11,722,096 |
| Accounts Receivable | $1,543,160 | $1,975,716 | $815,325 | $1,733,306 |
| Allowance For Doubtful Accounts Receivable | $-135,646 | $-5,829 | $-4,373 | $-212,413 |
| Gross Accounts Receivable | $1,678,806 | $1,981,545 | $819,698 | $1,945,719 |
| Cash Cash Equivalents And Short Term Investments | $18,140,841 | $22,419,266 | $14,319,234 | $10,467,357 |
| Cash And Cash Equivalents | $9,817,254 | $7,476,247 | $14,319,234 | $10,467,357 |
| Investmentin Financial Assets | - | $0 | $19,470,400 | $20,323,400 |
| Restricted Cash | - | $0 | $659,779 | $2,140,016 |
| Other Non Current Assets | - | - | $172,911 | $188,913 |
| Other Current Assets | - | - | $-1 | - |
| Current Deferred Assets | - | - | - | $0 |
| Debt | ||||
| Total Debt | $0 | $577,850 | $1,768,623 | $8,029,045 |
| Long Term Debt And Capital Lease Obligation | $0 | $24,575 | $72,537 | $106,180 |
| Current Debt And Capital Lease Obligation | - | $553,275 | $1,696,086 | $7,922,865 |
| Current Debt | - | $479,715 | $1,672,227 | $7,867,018 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,910,379 | $6,906,593 | $9,563,081 | $18,684,805 |
| Total Non Current Liabilities Net Minority Interest | $134,394 | $246,454 | $382,480 | $509,925 |
| Non Current Deferred Liabilities | $134,394 | $221,879 | $309,943 | $403,745 |
| Current Liabilities | $8,775,985 | $6,660,139 | $9,180,601 | $18,174,880 |
| Current Deferred Liabilities | $568,502 | $1,105,130 | $677,960 | $2,836,181 |
| Payables And Accrued Expenses | $8,207,483 | $5,001,734 | $6,806,555 | $7,415,834 |
| Payables | $7,292,451 | $3,796,185 | $6,105,292 | $6,948,996 |
| Total Tax Payable | $315,328 | $203,498 | $815,811 | $305,305 |
| Income Tax Payable | $1,166 | $127,885 | $142,255 | $148,204 |
| Accounts Payable | $4,125,597 | $3,592,687 | $5,289,481 | $6,643,691 |
| Current Notes Payable | - | $0 | $1,531,649 | $7,867,018 |
| Equity | ||||
| Common Stock Equity | $42,743,844 | $42,792,133 | $53,052,142 | $54,858,606 |
| Total Equity Gross Minority Interest | $44,093,349 | $44,351,401 | $54,963,536 | $56,668,458 |
| Stockholders Equity | $42,743,844 | $42,792,133 | $53,052,142 | $54,858,606 |
| Gains Losses Not Affecting Retained Earnings | $1,923,953 | $425,246 | $1,072,451 | $3,714,187 |
| Other Equity Adjustments | $1,923,953 | $425,246 | $1,072,451 | $3,714,187 |
| Retained Earnings | $4,349,377 | $5,896,373 | $15,509,177 | $14,693,905 |
| Long Term Equity Investment | $3,359,786 | $606,005 | $617,570 | $639,466 |
| Other | ||||
| Ordinary Shares Number | $7,226,480 | $7,150,000 | $7,150,000 | $7,150,000 |
| Share Issued | $7,226,480 | $7,150,000 | $7,150,000 | $7,150,000 |
| Tangible Book Value | $38,204,497 | $39,368,551 | $51,325,214 | $52,930,673 |
| Invested Capital | $42,743,844 | $43,271,848 | $54,724,369 | $62,725,624 |
| Working Capital | $20,993,225 | $27,852,482 | $20,853,388 | $22,190,273 |
| Capital Lease Obligations | $0 | $98,135 | $96,396 | $162,027 |
| Total Capitalization | $42,743,844 | $42,792,133 | $53,052,142 | $54,858,606 |
| Minority Interest | $1,349,505 | $1,559,268 | $1,911,394 | $1,809,852 |
| Additional Paid In Capital | $36,410,931 | $36,410,931 | $36,410,931 | $36,390,931 |
| Capital Stock | $59,583 | $59,583 | $59,583 | $59,583 |
| Common Stock | $59,583 | $59,583 | $59,583 | $59,583 |
| Non Current Deferred Revenue | $134,394 | $221,879 | $309,943 | $403,745 |
| Long Term Capital Lease Obligation | $0 | $24,575 | $72,537 | $106,180 |
| Current Deferred Revenue | $568,502 | $1,105,130 | $677,960 | $2,836,181 |
| Current Capital Lease Obligation | $0 | $73,560 | $23,859 | $55,847 |
| Line Of Credit | $0 | $479,715 | $140,578 | $0 |
| Current Accrued Expenses | $915,032 | $1,205,549 | $701,263 | $466,838 |
| Dueto Related Parties Current | $2,851,526 | $0 | - | - |
| Investments And Advances | $3,359,786 | $606,005 | $20,087,970 | $20,962,866 |
| Net PPE | $14,910,911 | $12,705,008 | $12,291,943 | $11,481,278 |
| Accumulated Depreciation | $-24,112,010 | $-22,060,348 | $-21,916,969 | $-23,045,753 |
| Gross PPE | $39,022,921 | $34,765,356 | $34,208,912 | $34,527,031 |
| Construction In Progress | $6,300,632 | $3,502,125 | $3,220,089 | $4,264,079 |
| Machinery Furniture Equipment | $19,203,521 | $18,314,481 | $19,054,023 | $20,433,076 |
| Buildings And Improvements | $13,518,768 | $12,948,750 | $11,934,800 | $9,829,876 |
| Properties | $13,518,768 | $12,889,450 | $0 | $0 |
| Inventories Adjustments Allowances | $-95,756 | $-885,709 | $-523,465 | $-125,146 |
| Finished Goods | $2,417,906 | $2,887,031 | $4,078,142 | $5,502,591 |
| Work In Process | $400,253 | $237,987 | $748,845 | $832,499 |
| Raw Materials | $2,327,285 | $2,752,126 | $4,575,964 | $6,285,887 |
| Other Short Term Investments | $8,323,587 | $14,943,019 | $0 | - |
| Other Properties | - | $59,300 | - | - |
| Available For Sale Securities | - | - | $19,470,400 | $20,323,400 |
Fetched: 2026-06-13
Cash Flow Statement (Annual)
| Metric | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,387,233 | $-3,401,880 | $9,395,236 | $-3,148,340 |
| Operating Activities | ||||
| Operating Cash Flow | $544,238 | $312,209 | $12,654,188 | $345,034 |
| Cash Flow From Continuing Operating Activities | $544,238 | $312,209 | $12,654,189 | $345,034 |
| Operating Gains Losses | $306,528 | $-4,016 | $-31,441 | $-69,494 |
| Investing Activities | ||||
| Capital Expenditure | $-3,931,471 | $-3,714,089 | $-3,258,952 | $-3,493,374 |
| Investing Cash Flow | $983,418 | $-4,742,445 | $-3,258,952 | $-24,200,032 |
| Cash Flow From Continuing Investing Activities | $983,418 | $-4,742,445 | $-3,258,952 | $-24,200,032 |
| Net Other Investing Changes | - | - | $-1 | - |
| Financing Activities | ||||
| Financing Cash Flow | $-491,728 | $-2,921,084 | $-5,937,529 | $23,993,338 |
| Cash Flow From Continuing Financing Activities | $-491,728 | $-2,921,084 | $-5,937,529 | $23,993,338 |
| Cash Dividends Paid | $0 | $-1,787,517 | $0 | - |
| Dividends Received Cfi | $56,198 | $0 | $0 | - |
| Issuance Of Capital Stock | - | $0 | $0 | $23,869,641 |
| Net Other Financing Charges | - | $56,711 | - | - |
| Common Stock Dividend Paid | - | $-1,787,517 | $0 | - |
| Net Common Stock Issuance | - | $0 | $0 | $23,869,641 |
| Common Stock Issuance | - | $0 | $0 | $23,869,641 |
| Other | ||||
| Repayment Of Debt | $-491,728 | $-1,686,500 | $-9,142,070 | $-7,681,081 |
| Issuance Of Debt | $0 | $496,222 | $3,204,541 | $7,804,778 |
| Interest Paid Supplemental Data | $4,262 | $3,656 | $122,237 | $152,499 |
| Income Tax Paid Supplemental Data | $21,910 | $27,440 | $0 | $820,972 |
| End Cash Position | $9,817,254 | $7,476,247 | $14,979,013 | $12,607,373 |
| Beginning Cash Position | $7,476,247 | $14,979,013 | $12,607,373 | $11,867,130 |
| Effect Of Exchange Rate Changes | $1,305,079 | $-151,446 | $-1,086,067 | $601,903 |
| Changes In Cash | $1,035,928 | $-7,351,320 | $3,457,707 | $138,340 |
| Net Issuance Payments Of Debt | $-491,728 | $-1,190,278 | $-5,937,529 | $123,697 |
| Net Short Term Debt Issuance | $-491,728 | $-1,190,278 | $-5,937,529 | $-7,681,081 |
| Short Term Debt Payments | $-491,728 | $-1,686,500 | $-9,142,070 | $-7,681,081 |
| Short Term Debt Issuance | $0 | $496,222 | $3,204,541 | $0 |
| Net Investment Purchase And Sale | $4,858,691 | $-1,000,000 | $0 | $-20,000,000 |
| Sale Of Investment | $6,263,629 | $0 | $0 | $0 |
| Purchase Of Investment | $-1,404,938 | $-1,000,000 | $0 | $-20,000,000 |
| Net Business Purchase And Sale | $0 | $-28,356 | $0 | $-706,658 |
| Purchase Of Business | $0 | $-28,356 | $0 | $-706,658 |
| Net Intangibles Purchase And Sale | $-1,078,215 | $-1,865,406 | $-26,683 | $-1,810 |
| Purchase Of Intangibles | $-1,078,215 | $-1,865,406 | $-26,683 | $-1,810 |
| Net PPE Purchase And Sale | $-2,853,256 | $-1,848,683 | $-3,232,269 | $-3,491,564 |
| Purchase Of PPE | $-2,853,256 | $-1,848,683 | $-3,232,269 | $-3,491,564 |
| Change In Working Capital | $785,703 | $1,112,186 | $8,751,332 | $-3,671,809 |
| Change In Other Working Capital | $-668,244 | $376,337 | $-2,120,490 | $-1,646,927 |
| Change In Other Current Liabilities | $-100,592 | $4,293 | $-55,036 | $-12,945 |
| Change In Other Current Assets | $-1,506,472 | $1,414,305 | $-1,198,646 | $-1,020,875 |
| Change In Payables And Accrued Expense | $839,988 | $-1,690,809 | $80,415 | $-24,384 |
| Change In Accrued Expense | $359,167 | $539,782 | $301,165 | $-897,496 |
| Change In Payable | $480,821 | $-2,230,591 | $-220,750 | $873,112 |
| Change In Account Payable | $378,976 | $-1,618,317 | $-805,443 | $2,015,833 |
| Change In Tax Payable | $101,845 | $-612,274 | $584,693 | $-1,142,721 |
| Change In Income Tax Payable | $101,845 | $-612,274 | $584,693 | $-1,142,721 |
| Change In Prepaid Assets | $-65,476 | $492,858 | $41,869 | $-855,977 |
| Change In Inventory | $958,655 | $3,403,831 | $2,230,723 | $46,801 |
| Change In Receivables | $1,327,844 | $-2,888,629 | $9,772,497 | $-157,502 |
| Changes In Account Receivables | $378,389 | $-1,223,035 | $1,027,671 | $-545,175 |
| Other Non Cash Items | $60,785 | $25,982 | $22,450 | $62,410 |
| Stock Based Compensation | $0 | $0 | $20,000 | $0 |
| Unrealized Gain Loss On Investment Securities | $819,432 | $5,527,381 | $853,000 | $-323,400 |
| Provisionand Write Offof Assets | $-741,433 | $426,138 | $258,080 | $84,141 |
| Deferred Tax | $-406,845 | $203,544 | $189,838 | $-46,187 |
| Deferred Income Tax | $-406,845 | $203,544 | $189,838 | $-46,187 |
| Depreciation Amortization Depletion | $1,237,229 | $1,143,064 | $1,224,672 | $1,201,229 |
| Depreciation And Amortization | $1,237,229 | $1,143,064 | $1,224,672 | $1,201,229 |
| Amortization Cash Flow | $101,846 | $65,688 | $52,028 | - |
| Amortization Of Intangibles | $101,846 | $65,688 | $52,028 | - |
| Depreciation | $1,135,383 | $1,077,376 | $1,172,644 | $1,263,639 |
| Earnings Losses From Equity Investments | $204,648 | $0 | $0 | - |
| Gain Loss On Investment Securities | $101,354 | $-4,016 | $-40,196 | $-69,494 |
| Net Income From Continuing Operations | $-1,517,161 | $-8,122,070 | $1,366,257 | $3,108,144 |
| Net Long Term Debt Issuance | - | - | $-2,885,585 | $7,804,778 |
| Long Term Debt Payments | - | - | $-6,090,126 | $-7,681,081 |
| Long Term Debt Issuance | - | - | $3,204,541 | $7,804,778 |
Fetched: 2026-06-13